Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, L.
Right arrow Articles by Coomber, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, L.
Right arrow Articles by Coomber, B. L.
Agricola
Right arrow Articles by Song, L.
Right arrow Articles by Coomber, B. L.
Biology of Reproduction 60, 1-7 (1999)
© 1999 Society for the Study of Reproduction, Inc.


Articles

Production of Gelatinases and Tissue Inhibitors of Matrix Metalloproteinases by Equine Ovarian Stromal Cells In Vitro1

Lifu Songa, David G. Porter3,a, and Brenda L. Coomber2,a

a Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario,Canada N1G 2W1


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) play very important roles in extracellular matrix (ECM) remodeling in ovarian follicle growth and ovulation. Equine follicles are embedded in cortex that is at the center of the ovary, and they must expand/emigrate to the fossa, the only site in the ovary for ovulation. Therefore, equine ovarian stromal cells (EOSC) are probably involved in ECM remodeling during follicle growth. This study examined whether cultured EOSC synthesize gelatinases and TIMPs, molecules essential for ECM remodeling in other systems. Results showed that cultured EOSC (passage 3–8) had a fibroblast-like morphology and were positive for {alpha}-smooth muscle actin and type I procollagen by immunostaining. Gelatinase A (MMP-2), gelatinase B (MMP-9), TIMP-1, and TIMP-2 were present in EOSC-conditioned medium, and TIMP-3 in ECM of EOSC. Transforming growth factor ß significantly stimulated the activity of gelatinases A and B and TIMP-1 in conditioned medium from EOSC (p < 0.05). Phorbol 12-myristate 13-acetate also significantly stimulated the activity of gelatinases A and B and TIMP-1 in conditioned medium and of TIMP-3 in ECM (p < 0.05). Our results suggest that EOSC produce important components of the ECM remodeling machinery and, therefore, may play a role in the ECM remodeling during follicle growth in this species.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play very important roles in extracellular matrix (ECM) remodeling in many physiological conditions, including ovarian follicle growth and ovulation [1, 2]. Gelatinase A (MMP-2, 72-kDa type IV collagenase) and gelatinase B (MMP-9, 92-kDa type IV collagenase), members of the MMP family, have been identified in the ovaries of humans, rats, and mice [35]. TIMPs are present in the ovaries of humans, rats, cows, and sheep [48]. Gelatinases A and B are able to digest various ECM components, including gelatin (denatured collagen I and III); collagen IV, V, VII, and XI; elastin; fibronectin; and laminin [1, 2]. Like other members of the MMP family, latent gelatinases A and B are secreted and form complexes with TIMPs. Progelatinase A forms complexes preferentially with TIMP-2, and progelatinase B forms complexes preferentially with TIMP-1 [9]. The TIMP family has four members: TIMP-1 (29 kDa), TIMP-2 (22 kDa), TIMP-3 (24 kDa) [10], and the recently identified TIMP-4 (22 kDa) [11]. In in vitro studies using chicken cells, both TIMP-1 and TIMP-2 were found to be present in conditioned medium, while TIMP-3 was predominantly bound to ECM [10]. TIMPs make tight associations with active gelatinases by forming noncovalent bimolecular complexes in a ratio of 1:1 which inhibit gelatinase activity [12].

The equine ovary has unique anatomic features: the cortex is in the center, and the medulla portion is superficial [13]. In the process of growth, the selected follicle expands from 50 µm in diameter at the primordial follicle stage to 5–7 cm in diameter at maturity. At the same time, the follicle migrates to the fossa, the only site from which a mature oocyte can be released from the ovary [13]. Therefore, in this species, the ovarian stromal tissue surrounding growing follicles undergoes extensive tissue remodeling in favor of the expansion and emigration of the follicle. The purpose of this study is to examine whether equine ovarian stromal cells (EOSC) might be involved in this process by producing components of the ECM remodeling machinery.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials

Minimum essential medium (MEM), L-glutamine, minimum nonessential amino acid solution, penicillin, streptomycin, gentamycin, fetal bovine serum (FBS), and trypsin-EDTA were purchased from Gibco-BRL (Burlington, ON, Canada). Bacterial collagenase type I, DNase I, phorbol 12-myristate 13-acetate (PMA), PMSF, 4-aminophenylmercuric acetate (APMA), and monoclonal human {alpha}-smooth muscle actin ({alpha}-SMA) antibody were purchased from Sigma Chemical Company (St. Louis, MO). Rabbit anti-human Von Willebrand factor was obtained from Dako Corporation (Carpinteria, CA). Rabbit antihuman type I procollagen was obtained from Cedar Lane (Hornby, ON, Canada). The reverse zymography kit, which contained crude gelatinase A and mouse purified TIMP-1, TIMP-2, and TIMP-3, was purchased from University Technologies International Inc. (Calgary, AB, Canada). Transforming growth factor (TGF) ß1 was purchased from R&D Systems Inc. (Minneapolis, MN).

Cell Culture

Ovaries from mature, cyclic mares (presence of mature corpus luteum indicated prior ovulation) were collected from a local abattoir (Barton Feeders, Owen Sound, ON, Canada) during the breeding season from April to September. The reproductive histories of the mares were not available. Ovaries were transported to the laboratory on ice in sterile Hanks' balanced salt solution (HBSS) with gentamycin (5 µg/ml). The outer surface of the ovaries was rinsed with 70% alcohol and washed twice with HBSS. The ovaries were bisected longitudinally within 4–6 h of collection. Eight ovaries judged as healthy from eight horses were chosen for the isolation of stromal cells. Stromal tissue from the apex (portion of the follicle oriented towards the ovarian fossa) of large follicles (3–4 cm in diameter) was collected and minced into 1-mm3 pieces. The tissue was digested by shaking in bacterial collagenase type I (125 U/ml) in serum-free MEM at 37°C for 3 h. During the last half hour of digestion, DNase I (50 U/ml) was added to the solution. After the tissue pieces were allowed to settle, crude debris was removed, and the supernatant containing EOSC was centrifuged at 250 x g. The supernatant was discarded, and the cell pellet was resuspended with HBSS. Viability of the EOSC was estimated by trypan blue dye exclusion. EOSC were grown in MEM supplemented with 10% (v:v) FBS, 2 mM L-glutamine, penicillin (100 U/ml), streptomycin (100 µg/ml), and gentamycin (5 µg/ml) at 37°C in a 5% CO2 atmosphere. Collection of ovaries and tissues was performed over two seasons, and established EOSC were pooled together in order to have sufficient cells for the whole study and to ensure that cells used in each experiment were from the same pool. Finally, EOSC were aliquoted into cryovials at a density of 1 x 106/ml in media containing dimethylsulfoxide (10%, v:v) and FBS (20%, v:v) and were frozen and stored in a liquid nitrogen tank. Cells between passages 3 and 8 were used in these experiments.

Immunocytochemistry

In order to characterize EOSC, {alpha}-SMA, Von Willebrand factor, and type I procollagen were chosen as markers. We verified that these antibodies cross-react with equine antigens, using appropriate controls (cultured equine uterine smooth muscle cells for {alpha}-SMA, cultured equine endothelial cells for Von Willebrand factor, and equine skin for type I procollagen). Cultured EOSC were immunostained as follows. Cells were cultured on sterile coverslips in MEM with 10% FBS overnight, then were rinsed with HBSS solution, dried completely at room temperature, and fixed in cold acetone for 10 min. The cells were incubated with antibodies to {alpha}-SMC (diluted 1:800 for 1 h) or Von Willebrand factor (1:20 for 1 h) or type I procollagen (1:50 overnight). Color reactions were then performed using secondary antibodies conjugated with horseradish peroxidase or alkaline phosphatase (1:20 for 30 min) and appropriate substrates.

Preparation of Samples for Enzyme Assays

EOSC at a density of 5 x 105 viable cells were seeded into 60-mm Petri dishes. MEM supplemented with 10% (v:v) FBS, 2 mM L-glutamine, penicillin (100 U/ml), streptomycin (100 µg/ml), and gentamycin (5 µg/ml) was changed every 48 h until the cells became confluent (6–8-day culture). The cells were cultured in serum-free MEM for another 24 h and then given various treatments. The conditioned medium was removed from Petri dishes and centrifuged at 250 x g to remove dead cells and debris. The supernatant was decanted and stored at -80°C. This conditioned medium was lyophilized and resuspended with ddH2O to produce a final solution that was 20-fold concentrated, to ensure that sufficient enzyme levels were present in samples for detection by zymography. The protein content in this concentrated conditioned medium was determined using a modified Bradford microassay (Bio-Rad Laboratories, Mississagua, ON, Canada), and samples were aliquoted in 500-µl vials and stored at -80°C until analysis.

ECM in Petri dishes was prepared as described previously [14]. Briefly, after collection of conditioned medium, the confluent cell monolayers were washed three times with PBS containing 5 mM EDTA/5 mM EGTA, then incubated at 37°C in the same solutions (5 ml) until the cells began to detach from the surface of the dishes. The dishes were washed several times with PBS until cells could no longer be found on culture dishes when inspected by phase contrast microscopy. The remaining ECM was washed three times with PBS, followed by ddH2O to remove the salts. Then, ECM was collected by scraping the dish bottom with a hard rubber spatula in 10 µl of 5-strength gel nonreducing loading buffer (Tris, 3%; glycerol, 50%; SDS, 20%) and 40 µl of ddH2O. The volume of collected buffer was adjusted with ddH2O to 50 µl, and samples were used immediately for reverse zymography or were stored at -80°C.

Gelatin Zymography

Active and latent forms of gelatinase A and B were detected by zymography, as described by Heussen and Dowdle [15]. In brief, samples were loaded with 5-strength nonreducing loading buffer in a ratio of 1:4 into SDS polyacrylamide (7.5% v:v) gel polymerized with 0.2% (w:v) calf skin gelatin. After electrophoresis, gels were washed with 2.5% Triton X-100 (2 x 30 min), then rinsed in ddH2O. After being washed in the incubation buffer (50 mM Tris, 5 mM CaCl2, 1µM ZnCl2, pH 8) for 30 min, gels were incubated with the incubation buffer at 37°C overnight. Gels were stained with 0.1% Coomassie brilliant blue G-250 dye for 30 min and destained in 5% methanol/7% glacial acetic acid. Since gelatinases A and B degrade gelatin present in the acrylamide gel, clear lysis bands indicate the absence of gelatin and the presence of gelatinases. In order to further identify the gelatinolytic activity in conditioned medium of EOSC, 10 mM EDTA (which chelates Zn2+ at the active site of MMPs and inhibits their activity [16]), or 1 mM PMSF (which inhibits serine/cysteine proteases but not MMPs [17]), was incorporated into the incubation buffer. APMA (1 mM), which converts precursor MMPs to active forms [17], was added to some samples before electrophoresis. Gels were photographed using a Gel Print 2000i apparatus (Bio/Can Scientific, Mississauga, ON, Canada), and digitized images were saved for further densitometric analysis.

Reverse Gelatin Zymography

TIMPs were analyzed with reverse zymography as described by Hampton et al. [14], using a commercially available kit (University Technologies International, Inc.). Briefly, 12% SDS polyacrylamide gels were made with 0.2% calf skin gelatin and crude gelatinase A. Samples were loaded with 5-strength nonreducing loading buffer at a ratio of 1:4. After electrophoresis, gels were washed with 2.5% Triton X-100 (2 x 30 min) and rinsed in ddH2O. Gels were washed in incubation buffer for 30 min, then incubated with incubation buffer at 37°C overnight. Gels were stained and destained as described above. The activity of TIMPs resulted in the presence of dark blue bands on a clear background. Purified mouse TIMP-1, TIMP-2, and TIMP-3 were run as standards. Gels were photographed using a Gel Print 2000i apparatus, and digitized images were saved for further densitometric analysis.

Image Processing and Densitometric Analysis

Gels from zymography and reverse zymography were processed with a Gel Print 2000i apparatus. Digitized images of gelatinolytic bands of gelatinases A and B from gelatin zymography and gelatin bands corresponding to TIMP-1, TIMP-2, and TIMP-3 from reverse gelatin zymography were analyzed on a Macintosh computer equipped with the NIH software "Image" (version 1.60). The integration area of each band was measured, and values were expressed as a ratio of the control area from the same gel (no additional treatment; set to unity). Results were thereby standardized for each gel and expressed in dimensionless units. Results were obtained from 3 separate experiments for each condition.

Statistical Analysis

Densitometry results from different replicate gels were compared, and means were calculated for each experimental system. All data are presented as the mean ± standard error of the mean (SEM). The software "Statistix" (V4.1) was used for statistical analysis. The significance of the differences among the means within each experiment was determined by one-way ANOVA, followed by Duncan's multiple-range procedure. Differences were considered significant at p < 0.05.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Characteristics of EOSC

Under phase contract microscopy, EOSC showed fibroblast-like morphology. The doubling time of EOSC in 10% FBS/MEM was about 20 h, and they could survive in serum-free medium for up to 7 days without any obvious ill effects (data not shown). The cells tended to form localized multilayered clumps of cells after they reached confluence. Most of the EOSC were positive for {alpha}-smooth muscle cell actin and type I procollagen (Fig. 1). Cultures were negative for Von Willebrand factor, indicating that our cultures were not contaminated with endothelial cells from the stromal microvessels (data not shown).



View larger version (135K):
[in this window]
[in a new window]
 
FIG. 1. Immunostaining for {alpha}-SMA or type I procollagen. a) EOSC stained with a monoclonal mouse anti-human {alpha}-SMA antibody followed by secondary antibodies conjugated with horseradish peroxidase. Occasional negative cells were seen (arrow). b) EOSC stained with a polyclonal rabbit anti-human type I procollagen antibody, followed by secondary antibodies conjugated with alkaline phosphatase. Scale bar = 5 µm.

Characteristics of Gelatinase Activity

In conditioned medium collected from EOSC cultured without any additional treatment, two major bands indicating gelatinolytic activity were obtained, as detected by gelatin zymography. The gelatinolytic activity at approximately 72 kDa (putative progelatinase A) was predominant (Fig. 2, whereas gelatinolytic activity at approximately 92 kDa (putative progelatinase B) was weak (Fig. 3a). In the presence of 1 mM APMA, which activates latent progelatinases, two additional faint bands at 68 and 82 kDa, thought to represent activated gelatinase A and B, respectively, were detected. In the presence of 10 mM EDTA (which inactivates MMPs by chelating Zn2+), gelatinolytic activity at both 72 and 92 kDa was completely inhibited (Fig. 2, lane c); the presence of 1 mM PMSF (which is not capable of inhibiting MMPs) had no effect on the gelatinolytic activity in conditioned medium from EOSC (Fig. 2, lane d). In order to determine whether the enzymes were gelatin-specific, fibrinogen or {alpha}-casein were used as substrates for zymography, instead of gelatin. For the substrates tested, the enzyme activity in EOSC samples was absent on fibrinogen (Fig. 2, lane e) and {alpha}-casein zymograms (Fig. 2, lane f).



View larger version (51K):
[in this window]
[in a new window]
 
FIG. 2. Detection by zymography of gelatinase activity present in EOSC-conditioned medium. Equivalent amounts of total protein (0.5 µg/lane) were loaded onto lanes of 7.5% acrylamide gel. Lanes: a) Gelatin zymogram; b) sample was incubated with 1 mM 4-APMA for 4 h before electrophoresis; c) gelatin zymogram was incubated in the presence of 10 mM ethylenediaminetetraacetic acid; d) gelatin zymogram was incubated in the presence of 1 mM PMSF; e) fibrinogen zymogram; f) {alpha}-casein zymogram.



View larger version (43K):
[in this window]
[in a new window]
 
FIG. 3. Gelatinase activity in conditioned medium from EOSC treated with TGFß (1–10 ng/ml) or PMA (5–20 ng/ml), as detected by gelatin zymography. a) Representative gelatin zymogram. Equal amounts of total protein (0.5 µg/lane) were loaded into the wells of 7.5% acrylamide gels. b) Densitometric analysis. Each column represents mean density (± SEM) of samples from 3 separate experiments. Bars with different letters indicate significant differences. p < 0.05.

Effects of Different Doses of TGFß or PMA on Gelatinase Production of EOSC

TGFß and PMA are involved in regulation of gelatinases in many in vitro systems. Conditioned medium of EOSC treated with TGFß (1–10 ng/ml) or PMA (5–20 ng/ml) for 48 h was examined by gelatin zymography in three experiments. An example of a gelatin zymogram from one experiment (Fig. 3) showed that both TGFß and PMA increased gelatinolytic bands corresponding to latent gelatinase A (72 kDa) and latent gelatinase B (92 kDa) activities (Fig. 3a). In addition, TGFß at a concentration of 5 ng/ml increased active gelatinase A activity, and PMA increased active gelatinase B activity. Densitometric analysis demonstrated that increasing concentrations of TGFß resulted in a significant increase of latent gelatinase A and latent gelatinase B activities (Fig. 3b). Densitometric analysis also showed that stimulation by TGFß at a dose of 5 ng/ml caused a 2.1-fold increase of gelatinolytic bands corresponding to latent gelatinase A activity compared to control values. Stimulation by TGFß at a dose of 10 ng/ml resulted in a 3.5-fold increase of gelatinolytic bands representing latent gelatinase B activity. The phorbol ester PMA significantly increased latent gelatinase A activity at the lowest concentration of 5 ng/ml and continued to cause significant further increases at 10 and 20 ng/ml. Phorbol ester PMA at 20 ng/ml caused a 2.2-fold increase in latent gelatinase A activity compared to that of control. Phorbol ester PMA also caused a significant increase in latent gelatinase B activity. However, the maximal stimulatory effects of a 4-fold increase in latent gelatinase B activity was induced by PMA at concentration of 5 ng/ml. With increased concentrations from 5 to 20 ng/ml, PMA induced active gelatinase B activity. Densitometric analysis for active gelatinase B activity (86 kDa) was not performed because of the lack of detectable active gelatinase B activity in the control samples.

Characteristics of TIMPs Produced by EOSC

Reverse gelatin zymography revealed that cultured EOSC secreted three factors that inhibited gelatinase activity (Fig. 4a). Two inhibitors in conditioned medium were approximately 29 and 22 kDa in size, while the third, in ECM, was approximately 24 kDa in size. In SDS-PAGE gels without gelatin and gelatinase, EOSC-conditioned medium or ECM did not contain visible proteins in the range of 21–30 kDa (Fig. 4b). Therefore, these three bands in Figure 4a represented undegraded gelatin; thus gelatinases added into the gels as part of the reverse zymography protocol were inhibited by these three factors. The molecular masses of two inhibitors in conditioned medium were very close to those of mouse TIMP-1 and TIMP-2; the molecular mass of the third factor bound to ECM was similar to that of mouse TIMP-3 (Fig. 4c). These three inhibitors remained partially active at pH 4.5 (Fig. 4d) or when heated to 90°C for 70 min (Fig. 4e).



View larger version (66K):
[in this window]
[in a new window]
 
FIG. 4. Detection by reverse zymography of TIMPs produced by cultured EOSC. These photographs are representative of 3 experiments run under the same conditions. C, Conditioned medium; E, ECM; M, molecular weight marker; S, purified mouse TIMP-1, TIMP-2, and TIMP-3 as standards. a) Reverse gelatin zymogram of samples. Note the presence of spared gelatin bands of approximately 29 and 22 kDa in lane C and of 24 kDa in lane E. b) Samples in plain SDS-PAGE gel (without gelatin and MMP preparation). Note the absence of detectable protein bands of 20–39 kDa. c) Samples and standards without heating and at pH 7.5. d) Samples and standards were acidified to pH 4.5. e) Samples and standards were heated at 90°C for 70 min. In c, d, and e, the gelatin inhibiting activity is spared for both samples and TIMP standards.

Effects of Different Doses of TGFß or PMA on TIMP Production by EOSC

The effects of increasing concentrations of TGFß (1–10 ng/ml) or PMA (5–20 ng/ml) on TIMP-1 and TIMP-2 activity in conditioned medium were assessed by reverse gelatin zymography. EOSC were treated with TGFß or PMA for 48 h. A representative reverse gelatin zymogram shows two bands representing TIMP-1 and TIMP-2 activity in conditioned medium of EOSC (Fig. 5a). Densitometric analysis showed that TGFß at 5 and 10 ng/ml or PMA at all concentrations tested significantly increased TIMP-1 activity over control values in conditioned medium of EOSC (Fig. 5b). Maximum increases of 3.6- and 3.3-fold in TIMP-1 activity were caused by TGFß at 10 ng/ml and PMA at 20 ng/ml, respectively, compared to control values. TGFß at concentrations of 5 and 10 ng/ml, and PMA at concentrations of 5 and 10 ng/ml also caused slight increases in TIMP-2 activity. However, these increases were not statistically significant compared to control values. In ECM, TGFß had no significant effect on TIMP-3 activity even at the concentration of 10 ng/ml. Phorbol ester PMA at 20 ng/ml caused a significant increase of TIMP-3 activity at 5, 10, and 20 ng/ml (Fig. 6).



View larger version (47K):
[in this window]
[in a new window]
 
FIG. 5. Activity of TIMP-1 and -2 in conditioned medium of EOSC treated with TGFß (1–10 ng/ml) or PMA (5–20 ng/ml), as detected by reverse zymography. Equal amounts of total protein (0.5 µg/lane) were loaded into the wells of 12.5% acrylamide gels. a) A reverse gelatin zymogram. b) Densitometric analysis. Each column represents mean density (± SEM) of samples from 3 separate experiments. Bars with different letters indicate significant differences. p < 0.05.



View larger version (56K):
[in this window]
[in a new window]
 
FIG. 6. TIMP-3 activity in ECM of EOSC after exposure to TGFß (1–10 ng/ml) or PMA (5–20 ng/ml), as detected by reverse zymography. a) A representative reverse gelatin zymogram. Equal amounts of sample (15 µl/lane) were loaded into the wells of 12.5% acrylamide gels. b) Densitometric analysis. Each column represents mean density (± SEM) of samples from 3 separate experiments. Bars with different letters indicate significant differences. p < 0.05.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The results of this study demonstrate that cells obtained from stromal tissue at the apex of developing follicles in the equine ovary are fibroblast-like in shape and express type I procollagen and {alpha}-SMA. Bovine ovary stromal cells assume a fibroblast-like morphology in vitro [18]. Other authors have reported {alpha}-SMA-positive cells in the stroma of human ovaries [19, 20]. While the EOSC can form multilayered aggregations under crowded culture conditions, EOSC cells in this study did not display the classic "hill and valley" morphology highly characteristic of smooth muscle cells in vitro which is seen in our cultures of equine uterine smooth muscle cells. Although EOSC are strongly positive for type I procollagen immunostaining and have a fibroblast-like morphology, they showed neither the classic spindle shape and motile morphology, nor the contact inhibition of "typical" connective tissue fibroblasts [21]. On the basis of these characteristics, we postulate that the EOSC are most likely myofibroblasts, a cell type first identified in 1971 [22] and reported to express characteristics of both smooth muscle cells and fibroblasts [23, 24]. Myofibroblasts are typically found in connective tissues undergoing remodeling [25]. In addition to their contraction function, myofibroblasts have been found to take part in tissue remodeling by producing several proteolytic enzymes, such as urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor by myofibroblasts of human breast cancer [26], and TIMPs by human skin fibroblasts [24]. Thus, myofibroblasts in equine ovary may take part in the matrix remodeling required for follicle growth.

Histological and biochemical changes have been observed at the follicular apex in several other species. An electron microscope study of rabbit ovaries documented the disappearance of the collagen bundles in the apex wall of preovulatory follicles [27]. Degradation of ECM in this apical region in sheep ovaries was significantly enhanced in comparison to ECM degradation in basal tissue of ovarian follicles [28]. In rabbits, tissue at the follicular apex contains more MMP-1, demonstrated by immunohistochemistry, than do other areas of the follicle wall [29]. These results indicate that cells within the follicle apex are possibly more important for follicle expansion, migration, and ovulation than cells elsewhere in the follicle wall.

EOSC secreted enzymes of approximately 72 and 92 kDa into conditioned medium, and these enzymes possessed gelatinolytic activity. Conditioned medium of EOSC treated with APMA, a substance used in vitro to activate latent forms of gelatinases, contained two extra enzymes of approximately 68 and 82 kDa. The gelatinolytic activity normally observed in conditioned medium from EOSC was completely abolished in the culture medium by inclusion of EDTA, which chelates with Zn2+ at the active site of MMPs and leads to the inhibition of MMP activities [16]. PMSF, a serine/cysteine protease inhibitor but not an MMP inhibitor [17], did not inhibit gelatinolytic activity in EOSC-conditioned medium. The enzyme activity was not found when fibrinogen or {alpha}-casein was used as the substrate for zymography, suggesting that the enzymes in conditioned medium causing gelatinolytic bands were gelatin-specific. Taken together, the evidence supports our conclusion that the gelatinolytic activity at 72 kDa represents progelatinase A, while that at 92 kDa represents progelatinase B. The gelatinolytic activities at 68 and 82 kDa represent active gelatinases A and B, respectively.

Two proteins with inhibitory activity on gelatinases were found in EOSC-conditioned medium and had approximate molecular masses of 29 and 22 kDa, similar to mouse TIMP-1 and TIMP-2, respectively. A third inhibitor of 24 kDa was found exclusively in ECM and also had the same molecular mass as mouse TIMP-3. All these proteins were heat- and acid-resistant, consistent with the TIMP characteristics described by Cawston and coworkers [30]. Taken together, the evidence supports our conclusion that the two inhibitors in conditioned medium represent TIMP-1 and TIMP-2, and the inhibitor in ECM represents TIMP-3. To our knowledge, this is the first report showing that equine cells synthesize gelatinases and TIMPs in vitro. Our study also demonstrates that ovarian stromal cells may play roles in tissue remodeling during follicle growth, as reported for thecal and granulosa cells [48, 31].

In this study, gelatinases and TIMPs were identified in conditioned medium of EOSC simultaneously. Such a phenomenon is demonstrated in other ovarian cell types. In the ovary, theca cells, granulosa cells, and corpora lutea synthesize both gelatinases and TIMPs simultaneously [4,5,31]. It is believed that coexpression of MMPs and TIMPs is required to maintain proteolytic homeostasis and provide localized control of ECM degradation in the ovary [32].

TGFß is thought to be an intraovarian factor involved in follicle development. Studies demonstrate that TGFß is present in human ovarian stromal, granulosa, and theca cells [33], and porcine theca cells [34] during follicle growth. Evidence shows that TGFß may act on the target cells in an autocrine/paracrine manner [34, 35]. On the other hand, TGFß is also involved in ECM remodeling in other tissues [36, 37]. Our study suggests that TGFß may play a role in ECM remodeling during equine follicle growth by regulating MMPs and TIMPs.

In general, TGFß is considered to increase accumulation of ECM by down-regulating gelatinase expression and/or by stimulating TIMPs [2]. However, different effects of TGFß on gelatinases or TIMPs have been reported. Several studies show that TGFß stimulated the production of both gelatinases A and B [38, 39], and one study showed that TGFß increased production of mRNA and protein for gelatinase A and TIMP-1 in cultured human glomerular mesangial cells [36]. Therefore, it seems that TGFß, in certain circumstances, may accelerate ECM remodeling by stimulating both MMPs and TIMPs. During follicle maturation, acceleration of ECM remodeling in stromal tissue would facilitate follicle expansion.

Graham and coworkers [40] demonstrated that TGFß was able to up-regulate levels of TIMP-2 mRNA in normal human trophoblasts. Other investigators reported that TGFß had inhibitory or no effects on TIMP-2 mRNA expression in different systems [41]. In primary bovine and human articular chondrocytes, TGFß increased TIMP-3 mRNA in a dose-dependent manner that required message transcription and de novo protein synthesis [42]. In the present study, TGFß failed to stimulate increased TIMP-3 activity in ECM produced by EOSC.

Phorbol ester PMA has been used to examine regulatory mechanisms in many studies of proteolytic enzymes, although it is a nonphysiological factor. It has been shown that PMA can induce the production of gelatinase B through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the promoter region of the gelatinase B gene [43] and can activate gelatinase A through protein kinase C-dependent mechanisms [4346]. In the present study, PMA led to increased levels of progelatinase B and of a form of lower molecular size (86 kDa), which represents activated gelatinase B. The induction and activation of progelatinase A was also observed in this study. Since the active gelatinase A at 68 kDa could not be separated from progelatinase A at 72 kDa by gelatin zymography in our study using 7.5% acrylamide gels, it was not possible to quantify the relative levels. Thus, in our study, PMA not only stimulated production but also activated both progelatinases A and B. The reason for this is not clear. However, similar to that in other cell types, MMP production by EOSC involves protein kinase C-dependent mechanisms, and the equine gene most likely contains a 12-O-tetradecanoylphorbol-13-acetate-responsive element in its promoter region [4345]. Phorbol ester PMA also induces the mRNA expression and protein synthesis of TIMP-1 and TIMP-2 [37, 44], but PMA is not reported to affect TIMP-3 at the mRNA and protein level in these studies. Our results are consistent with these previous reports.

In conclusion, cultured EOSC are able to synthesize gelatinases and TIMPs, and their activity is regulated by TGFß and PMA. This suggests that stromal cells in the ovary may actively take part in the ECM remodeling during follicle growth and ovulation in mares. Further studies are required to elucidate whether EOSC are also involved in matrix remodeling in vivo and whether this activity can be regulated by hormones and other growth factors involved in follicle growth.


    ACKNOWLEDGMENTS
 
The authors thank the personnel at Barton Feeders, Owen Sound, Ontario, Canada, for help in collecting tissue specimens. This work is dedicated to the memory of the late David G. Porter, in whose laboratory these studies were initiated.


    FOOTNOTES
 
1 Financial support provided by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Dynasty Equine Trust Fund, and the Ontario Ministry of Agriculture, Food and Rural Affairs. Back

2 Correspondence. FAX: 519 767 1450; bcoomber{at}uoguelph.ca Back

3 Deceased. Back

Accepted: August 17, 1998.

Received: March 9, 1998.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992; 14:455–463.[CrossRef][Medline]
  2. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, Decarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4:197–250.[Abstract/Free Full Text]
  3. Hirsch B, Leonhardt S, Jarry H, Reich R, Tsafriri A, Wuttke W. In vivo measurement of rat ovarian collagenolytic activities. Endocrinology 1993; 133:2761–2765.[Abstract/Free Full Text]
  4. Reich R, Daphna ID, Chun SY, Popliker M, Slager R, Adelmann GBC, Tsafriri A. Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: role of eicosanoids. Endocrinology 1991; 129:1869–1875.[Abstract/Free Full Text]
  5. Curry TE Jr, Dean DD, Sanders D, Pedigo NG, Jones PBC. The role of ovarian proteases and their inhibitors in ovulation. Steroids 1989; 54:501–521.[CrossRef][Medline]
  6. Chun SY, Popliker M, Reich R, Tsafriri A. Localization of preovulatory expression of plasminogen activator inhibitor type-1 and tissue inhibitor of metalloproteinase type-1 mRNAs in the rat ovary. Biol Reprod 1992; 47:245–253.[Abstract]
  7. Freudenstein J, Wagner S, Luck RM, Einspanier R, Scheit KH. mRNA of bovine tissue inhibitor of metalloproteinase: sequence and expression in bovine ovarian tissue. Biochem Biophys Res Commun 1990; 171:250–256.[CrossRef][Medline]
  8. Smith MF, Moor RM. Secretion of a putative metalloproteinase inhibitor by ovine granulosa cells and luteal tissue. J Reprod Fertil 1991; 91:627–635.[Abstract/Free Full Text]
  9. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He CS. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 1989; 86:8207–8211.[Abstract/Free Full Text]
  10. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP. A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 1992; 267:17321–17326.[Abstract/Free Full Text]
  11. Greene J, Wang M, Liu YE, Rayond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996; 271:30375–30380.[Abstract/Free Full Text]
  12. Fridman R, Bird RE, Hoyhtya M, Oelkuct M, Komarek D, Liang CM, Berman ML, Liotta LA, Stetler-Stevenson WG, Fuerst TR. Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme. Biochem J 1993; 289:411–416.
  13. Ginther OJ. Reproductive Biology of the Mare: Basic and Applied Aspects. Cross Plains, WI: Equiservices; 1992: 173–232.
  14. Hampton AL, Butt AR, Riley SC, Salamonsen LA. Tissue inhibitors of metalloproteinases in endometrium of ovariectomized steroid-treated ewes and during the estrous cycle and early pregnancy. Biol Reprod 1995; 53:302–311.[Abstract]
  15. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrate. Anal Biochem 1980; 102:196–202.[CrossRef][Medline]
  16. Rao VH, Bridge JA, Neff JR, Schaefer GB, Buehler BA, Vishwanatha JK, Pollock RE, Nicolson GL, Yamamoto M, Gokaslam ZL. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone. Clin Exp Metastasis 1995; 13:420–426.[CrossRef][Medline]
  17. Salamonsen LA, Nagase H, Suzuki R, Woolley DE. Production of matrix metalloproteinase 1 (interstitial collagenase) and matrix metalloproteinase 2 (gelatinase A; 72 kDa gelatinase) by ovine endometrial cells in vitro: different regulation and preferential expression by stromal fibroblasts. J Reprod Fertil 1993; 98:583–589.[Abstract/Free Full Text]
  18. Vigne JL, Halburnt LL, Skinner MK. Characterization of bovine ovarian surface epithelium and stromal cells: identification of secreted proteins. Biol Reprod 1994; 51:213–221.
  19. Czernobisky B, Shezen E, Lifschitz-Mercer B, Fogel M, Luzon A, Jacob, Skalli O, Gabbiani G. Alpha smooth muscle actin ({alpha}-SM actin) in normal human ovaries, in ovarian stromal hyperplasia and in ovarian neoplasms. Arch B Cell Pathol 1989; 57:55–61.
  20. Santini D, Ceccarelli C, Mazzoleni G, Pasquinelli G, Jasonni VM, Martinelli GN. Demonstration of cytokeratin intermediate filaments in oocytes of the developing and adult human ovary. Histochemistry 1993; 99:311–319.[CrossRef][Medline]
  21. Freshney RI. Cultures of Animal Cells. New York: Alan R. Liss, Inc.; 1994: 257–288.
  22. Gabbiani G, Ryan GB, Manjo G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27:549–550.[CrossRef][Medline]
  23. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994; 124:4021–4040.
  24. Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes MD. Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP) with two forms of TIMP-1. J Biol Chem 1995; 270:3423–3428.[Abstract/Free Full Text]
  25. Shi, Fard A, O’Brien J, Mannion JD, Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation 1996; 93:340–348.[Abstract/Free Full Text]
  26. Christensen L, Wiborg-Simonsen AC, Heegaard CW, Moestrup SK, Andersen JA, Andreasen PA. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas. Int J Can 1996; 66:441–452.[CrossRef][Medline]
  27. Espey LL, Coons JP, Marsh JM, LeMaire WJ. Effect of indomethacin on preovulatory change in the ultrastructure of rabbit graafian follicles. Endocrinology 1981; 108:1040–1048.[Abstract/Free Full Text]
  28. Murdoch WJ, McCormick RJ. Enhanced degradation of collagen within apical vs. basal wall of ovulatory ovine follicle. Am J Physiol 1992; 263:E221–225.
  29. Tadakuma H, Okamura H, Kitaoka M, Iyama K, Usuku G. Association of immunolocalization of matrix metalloproteinase 1 with ovulation in hCG-treated rabbit ovary. J Reprod Fertil 1993; 98:503–508.[Abstract/Free Full Text]
  30. Cawston TE, Galloway WA, Mercer E, Murphy G, Reynolds JJ. Purification of rabbit bone inhibitor of collagenase. Biochem J 1981; 195:159–166.[Medline]
  31. Lemaire WJ. Mechanism of mammalian ovulation. Steroids 1989; 54:455–469.
  32. Tsafriri A. Ovulation as a tissue remodeling process. Adv Exp Med Biol 1994; 377:121–140.
  33. Chegini N, Flanders KC. Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages. Endocrinology 1992; 130:1707–1715.[Abstract/Free Full Text]
  34. Engelhardt H, Tekpetey FR, Gore Langton RE, Armstrong DT. Regulation of steroid production in cultured porcine thecal cells by transforming growth factor-beta. Mol Cell Endocrinol 1992; 85:117–126.[CrossRef][Medline]
  35. Kubota T, Kamada S, Taguchi M, Aso T. Autocrine/paracrine function of transforming growth factor-beta 1 in porcine granulosa cells. Hum Reprod 1994; 9:2118–2122.[Abstract/Free Full Text]
  36. Marti HP, Lee L, Kashgarian M, Lovett DH. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kD type IV collagenase. Am J Pathol 1994; 144:82–94.[Abstract]
  37. Edwards DR, Leco KJ, Beaudry PP, Atadja PW, Veillette C, Riabowol KT. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp Gerontol 1996; 31:207–223.[CrossRef][Medline]
  38. Xie B, Dong Z, Fidler IJ. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J Immunol 1994; 152:3637–3644.[Abstract]
  39. Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 1993; 90:4577–4581.[Abstract/Free Full Text]
  40. Graham CH, Connelly I, MacDougall KR, Kerbel RS, Stetler-Stevenson WG, Lala PK. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp Cell Res 1994; 214:93–99.[CrossRef][Medline]
  41. Rydziel S, Varghese S, Canalis E. Transforming growth factor beta 1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures. J Cell Physiol 1997; 170:145–152.[CrossRef][Medline]
  42. Su S, Dehnade F, Zafarullah M. Regulation of tissue inhibitor of metalloproteinases-3 gene expression by transforming growth factor-beta and dexamethasone in bovine and human articular chondrocytes. DNA Cell Biol 1996; 15:1039–1048.[Medline]
  43. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8:395–405.[Medline]
  44. Hanemaaijer R, Koolwijk P, le-Clercq L, de-Vree WJ, van-Hinsbergh VW. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 1993; 296:803–809.
  45. Foda HD, George S, Conner C, Drews M, Tompkins DC, Zucker S. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab Invest 1996; 74:538–545.[Medline]
  46. Edwards DR, Mahadevan LC. Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors. EMBO J 1992; 11:2415–2424.[Medline]



This article has been cited by other articles:


Home page
ReproductionHome page
D. Rosairo, I. Kuyznierewicz, J. Findlay, and A. Drummond
Transforming growth factor-{beta}: its role in ovarian follicle development
Reproduction, December 1, 2008; 136(6): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. E. Starr, T. Dan, K. Minhas, P. E. Shewen, and B. L. Coomber
Potential Involvement of Gelatinases and Their Inhibitors in Mannheimia haemolytica Pneumonia in Cattle
Infect. Immun., August 1, 2004; 72(8): 4393 - 4400.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F.-C. Ke, L.-C. Chuang, M.-T. Lee, Y. J. Chen, S.-W. Lin, P. S. Wang, D. M. Stocco, and J.-J. Hwang
The Modulatory Role of Transforming Growth Factor {beta}1 and Androstenedione on Follicle-Stimulating Hormone-Induced Gelatinase Secretion and Steroidogenesis in Rat Granulosa Cells
Biol Reprod, May 1, 2004; 70(5): 1292 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. E. Curry Jr. and K. G. Osteen
The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle
Endocr. Rev., August 1, 2003; 24(4): 428 - 465.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. E. Curry Jr., L. Song, and S. E. Wheeler
Cellular Localization of Gelatinases and Tissue Inhibitors of Metalloproteinases During Follicular Growth, Ovulation, and Early Luteal Formation in the Rat
Biol Reprod, September 1, 2001; 65(3): 855 - 865.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. E. Curry Jr and K. G. Osteen
Cyclic Changes in the Matrix Metalloproteinase System in the Ovary and Uterus
Biol Reprod, May 1, 2001; 64(5): 1285 - 1296.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
G Manandhar, R. Moreno, C Simerly, K Toshimori, and G Schatten
Contractile apparatus of the normal and abortive cytokinetic cells during mouse male meiosis
J. Cell Sci., January 12, 2000; 113(23): 4275 - 4286.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, L.
Right arrow Articles by Coomber, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, L.
Right arrow Articles by Coomber, B. L.
Agricola
Right arrow Articles by Song, L.
Right arrow Articles by Coomber, B. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS